Halt the use of inaccurate Chinese lateral flow tests, with some already banned by the likes of the FDA. The UK has a wealth of capability of millions per week capacity to provide accurate lateral flow tests during a global shortage yet the UK Government have alleged to have limited access to the likes of Avacta PLC, Abingdon Health and Omega Diagnostics and Mologic, which has also included some of those companies in legal battles to recover monies invested on the alleged agreement with the DHSC and UK Government to provide manufacturing capacity. The significant home grown, UK diagnostic industry is being crippled by the UK Government only seeking to use billions of pounds of alleged inadequate Chinese tests. This has to stop and the UK Government must support UK companies